黑色素瘤和实体瘤中自体细胞治疗年度重大进展

Top advances of the year in autologous cellular therapy in melanoma and solid tumors.

实体瘤细胞治疗进展：欧洲视角与未来方向

Advances in cell therapy for solid tumours: European perspective and future directions.

T 细胞受体工程化 T 细胞治疗：快速演进的实体瘤治疗范式

T-Cell Receptor Engineered T-Cell Therapy: A Rapidly Evolving Treatment Paradigm for Solid Tumors.

肉瘤细胞治疗：现状与未来方向

Cell therapy in sarcoma: current landscape and future directions.

以 TCR 转导 T 细胞免疫治疗靶向恶性脑膜瘤中的 NY-ESO-1

Immunotherapeutic targeting of NY-ESO-1 in malignant meningiomas with TCR-transduced T-cells.

NY-ESO-1 TCR-T 在体外诱导脑膜瘤细胞溶解，其疗效与 NY-ESO-1 表达相关。

自体 T 细胞疗法治疗 HLA-A*02(+) 患者中 PRAME(+) 晚期实体瘤：一项 I 期试验

Autologous T cell therapy for PRAME(+) advanced solid tumors in HLA-A*02(+) patients: a phase 1 trial.

利用具有 T 细胞受体样特异性的抗体介导对细胞内蛋白质组的识别

Harnessing antibody-mediated recognition of the intracellular proteome with T cell receptor-like specificity.

实体瘤细胞治疗：毒性管理原则

Solid tumour cellular therapy - principles of toxicity management.

迈向应用 T 细胞受体治疗实体瘤的综合解决方案：综述

Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review.

在 HLA-A*02 合格患者中识别适于 TCR T 细胞治疗的 MAGE-A4 阳性肿瘤

Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients.